{"id":"aluminium-nicotinate","rwe":[],"tags":[{"label":"aluminium nicotinate","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"C10AD04","category":"atc"},{"label":"Active","category":"status"}],"phase":"unknown","safety":{"commonSideEffects":[]},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":"nicalex","offLabel":[],"synonyms":["aluminium nicotinate","alcotine","aluminate nicotinate","alunitine nicolex","nicalex"],"timeline":[],"brandName":"Nicalex","ecosystem":[],"mechanism":{"modality":"Small Molecule","drugClass":"aluminium nicotinate","explanation":"Think of blood flow like a highway system in your body. Nicalex helps to widen and improve the flow of traffic on these highways, allowing oxygen and nutrients to reach your cells more easily. This can help to reduce inflammation and improve overall health.","oneSentence":"Nicalex works by improving blood flow and reducing inflammation in the body.","technicalDetail":"Aluminium nicotinate is believed to exert its effects through a combination of vasodilation and anti-inflammatory mechanisms, although the exact molecular targets and pathways involved are not yet fully understood."},"_wikipedia":{"url":"https://en.wikipedia.org/wiki/Aluminium_nicotinate","title":"Aluminium nicotinate","extract":"Aluminium nicotinate is a niacin derivative used as a hypolipidemic agent."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/4764","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://clinicaltrials.gov/search?intr=aluminium%20nicotinate","fields":["trials"],"source":"ClinicalTrials.gov"},{"id":3,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=aluminium nicotinate","fields":["publications"],"source":"PubMed/NCBI"},{"id":4,"url":"https://en.wikipedia.org/wiki/Aluminium_nicotinate","fields":["history","overview"],"source":"Wikipedia"}],"_enrichedAt":"2026-03-30T08:39:35.020900","biosimilars":[],"competitors":[{"drugName":"nicotinic acid","drugSlug":"nicotinic-acid","fdaApproval":"1957-07-24","relationship":"same-class"}],"genericName":"aluminium nicotinate","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[{"drugId":"nicotinic-acid","brandName":"nicotinic acid","genericName":"nicotinic acid","approvalYear":"1957","relationship":"same-class"}],"trialDetails":[{"nctId":"NCT05879406","phase":"NA","title":"A Study to Evaluate the Efficacy and Safety of Clear Skin Formula on Mitigating Mild to Moderate Non-cystic Acne","status":"COMPLETED","sponsor":"Ablon Skin Institute Research Center","startDate":"2023-05-31","conditions":["Non-Cystic Acne"],"enrollment":40,"completionDate":"2024-01-23"},{"nctId":"NCT06522412","phase":"NA","title":"The Effects of Jing-Si Herbal Tea Liquid Packets and Jing-Si Herbal Tang Heng Power Drink","status":"ACTIVE_NOT_RECRUITING","sponsor":"Buddhist Tzu Chi General Hospital","startDate":"2024-05-01","conditions":["Inflammatory Marker","Gut Microbiome","Trimethylamine N-oxide","HbA1c","Atherosclerosis"],"enrollment":200,"completionDate":"2026-12"},{"nctId":"NCT01749371","phase":"PHASE2,PHASE3","title":"Vitamin E Supplementation in Burned Patients","status":"COMPLETED","sponsor":"The University of Texas Medical Branch, Galveston","startDate":"2013-02","conditions":["Burn"],"enrollment":31,"completionDate":"2017-09"},{"nctId":"NCT03648333","phase":"PHASE1","title":"Clinical Trial to Assess the Pharmacokinetic Characteristics of Lodivixx Tab. 5/160mg in Healthy Male Subjects (N=27)","status":"COMPLETED","sponsor":"Hanlim Pharm. Co., Ltd.","startDate":"2013-12","conditions":["Healthy Male Subjects"],"enrollment":27,"completionDate":"2014-06"},{"nctId":"NCT01819779","phase":"PHASE1","title":"Clinical Trial to Assess the Pharmacokinetic Characteristics of Lodivixx Tab. 5/160mg in Healthy Male Subjects (N=60)","status":"COMPLETED","sponsor":"Hanlim Pharm. Co., Ltd.","startDate":"2013-03","conditions":["Healthy Male Subjects"],"enrollment":53,"completionDate":"2013-11"},{"nctId":"NCT01324297","phase":"","title":"The Topical Niacin Skin Flush Test in First Episode Psychosis","status":"TERMINATED","sponsor":"Nova Scotia Health Authority","startDate":"2011-12","conditions":["Psychotic Disorders","Schizophrenia"],"enrollment":107,"completionDate":"2016-07"},{"nctId":"NCT00619060","phase":"PHASE1","title":"Topical Myristyl Nicotinate Cream on the Skin of Healthy Volunteers","status":"COMPLETED","sponsor":"University of Arizona","startDate":"2007-08","conditions":["Healthy"],"enrollment":22,"completionDate":"2008-07"},{"nctId":"NCT02458924","phase":"PHASE2,PHASE3","title":"Niacin Skin Flush Response in Patients With Schizophrenia","status":"COMPLETED","sponsor":"Isfahan University of Medical Sciences","startDate":"2014-01","conditions":["Schizophrenia"],"enrollment":100,"completionDate":"2014-09"},{"nctId":"NCT00773162","phase":"PHASE3","title":"Flushing in Social Anxiety Disorder on Seroquel","status":"COMPLETED","sponsor":"START Clinic for Mood and Anxiety Disorders","startDate":"2008-10","conditions":["Social Anxiety Disorder"],"enrollment":21,"completionDate":"2013-08"},{"nctId":"NCT00485888","phase":"PHASE2","title":"Flushing in Social Anxiety Disorder on Cipralex","status":"COMPLETED","sponsor":"START Clinic for Mood and Anxiety Disorders","startDate":"2008-10","conditions":["Social Anxiety Disorder"],"enrollment":71,"completionDate":"2013-08"},{"nctId":"NCT00152893","phase":"PHASE2","title":"To Determine if Chromium Nicotinate Supplementation Will Improve Insulin Resistance in HIV Patients With Metabolic Abnormalities","status":"COMPLETED","sponsor":"Johane Allard","startDate":"2002-08","conditions":["HIV Infections"],"enrollment":52,"completionDate":"2008-02"},{"nctId":"NCT01652339","phase":"PHASE1","title":"Clinical Trial to Assess the Pharmacokinetic Characteristics of Lodivixx Tab. 5/160mg in Healthy Male Subjects","status":"COMPLETED","sponsor":"Hanlim Pharm. Co., Ltd.","startDate":"2012-07","conditions":["Healthy Male Subjects"],"enrollment":40,"completionDate":"2012-12"},{"nctId":"NCT01574313","phase":"PHASE4","title":"Effect of Stellate Ganglion Block on Meniere's Disease","status":"COMPLETED","sponsor":"Chi Mei Medical Hospital","startDate":"2010-04","conditions":["Vertigo","Meniere Disease"],"enrollment":20,"completionDate":"2012-03"},{"nctId":"NCT01368328","phase":"PHASE3","title":"Effect of the Chromium Nicotinate on Type 2 Diabetes","status":"UNKNOWN","sponsor":"Universidade Federal de Goias","startDate":"2010-03","conditions":["Type 2 Diabetes"],"enrollment":57,"completionDate":"2011-09"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"MMSL":"2275","NDDF":"001052","CHEBI":"CHEBI:15940","VANDF":"4017661","RXNORM":"7393","UMLSCUI":"C0770544","ChEMBL_ID":"CHEMBL3707287","DRUGBANK_ID":"DB13576","PDB_CHEM_ID":" NIO","PUBCHEM_CID":"16098","SNOMEDCT_US":"273943001"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":15,"therapeuticAreas":["Hematology"],"atcClassification":{"source":"DrugCentral","atcCode":"C10AD04","allCodes":["C10AD04"]},"biosimilarFilings":[],"recentPublications":[],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"unknown","modality":"Small Molecule","firstApprovalDate":"","aiSummary":"Nicalex, also known as aluminium nicotinate, is a small molecule drug in the aluminium nicotinate class. Its exact target and mechanism of action are unknown, but it is believed to work by improving blood flow and reducing inflammation. Nicalex is not FDA-approved for any indications, and its commercial status, including patent status and generic availability, is unclear. As a result, key safety considerations and pharmacokinetic properties, such as half-life and bioavailability, are also unknown. Further research is needed to fully understand Nicalex's potential therapeutic applications and risks.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":true,"score":2}}